52144-34-0

Basic information

• Product Name: 2-Quinolinecarboxylic acid, 4-(phenylmethoxy)-
• CAS NO: 52144-34-0
• Molecular Formula: C17H13NO3
• Molecular Weight: 279.295
• Mol File: 52144-34-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-Quinolinecarboxylic acid, 4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Quinolinecarboxylic acid, 4-(phenylmethoxy)-(52144-34-0)
• EPA Substance Registry System: 2-Quinolinecarboxylic acid, 4-(phenylmethoxy)-(52144-34-0)

Safety Data

• Hazardous Substances Data: 52144-34-0(Hazardous Substances Data)

Upstream product

• 18436-69-6 4-chloro-2-ethoxycarbonylquinoline 
• 2785-29-7 benzyl potassium 
• 857762-80-2 4-benzyloxy-quinoline-2-carbonitrile 
• 1373835-84-7 2-benzyloxycarbonyl-4-benzyloxyquinoline 
• 94298-60-9 4-benzyloxy-quinoline-1-oxide 
• 492-27-3 kinurenic acid 
• 102028-50-2 methyl 4-(benzyloxy)quinoline-2-carboxylate 

Downstream Products

• 52144-03-3 4-benzyloxy-quinoline-2-carboxylic acid 1⁽²⁾H-tetrazol-5-ylamide 
• 710335-44-7 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-benzyloxycarbonylpropyl]aminocarbonyl-4-benzyloxyquinoline 
• 111271-61-5 N-(4-benzyloxy-[2]quinolyl)-diacetamide 
• 101569-92-0 4-benzyloxy-quinoline-2-carboxylic acid hydrazide 
• 101731-48-0 N-(4-benzyloxy-[2]quinolyl)-acetamide 
• 798576-75-7 4-benzyloxyquinoline-2-carboxylic acid [1(S)-(3,4-dibenzyloxy-5-oxo-2,5-dihydrofuran-2(R)-yl)-2-bromoethyl] ester 
• 400844-99-7 4-benzyloxyquinoline-2-carboxylic acid [2-(3,4-dibenzyloxy-5-oxo-2,5-dihydrofuran-2(R)-yl)-2(S)-hydroxyethyl] ester 
• 101444-60-4 4-benzyloxy-quinoline-2-carboxylic acid amide 
• 492-27-3 kinurenic acid 
• 102028-50-2 methyl 4-(benzyloxy)quinoline-2-carboxylate 

Relevant articles and documents

2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS

Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.

Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity

To improve the entry of certain drugs into brain, ascorbic acid (AA) conjugates of these drugs were synthesized and their capacity to interact with SVCT2 ascorbate transporters was explored. Kinetic studies clearly indicate that all of the conjugates were